Search This Blog

Thursday, December 21, 2023

Abbvie extends option agreement with Aldeyra for dry eye

 AbbVie extends co-development option with Aldeyra Therapeutics for dry eye treatment, paying a $5M fee

https://seekingalpha.com/news/4049443-abbvie-extends-option-agreement-aldeyra-dry-eye-candidate

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.